PCM
ADMA icon

Peregrine Capital Management’s ADMA Biologics ADMA Stock Holding History

Peregrine Capital Management’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-611,826
Closed -$5.51M – 284
2026
Q1 		$5.51M Buy
611,826
+140,370
+30% +$2.22M 0.2% 149
2025
Q4 		$8.6M Sell
471,456
-59,068
-11% -$996K 0.26% 107
2025
Q3 		$7.78M Buy
530,524
+73,868
+16% +$1.27M 0.23% 120
2025
Q2 		$8.32M Buy
456,656
+53,515
+13% +$1.09M 0.25% 108
2025
Q1 		$8M Sell
403,141
-33,056
-8% -$572K 0.27% 102
2024
Q4 		$7.48M Buy
436,197
+15,423
+4% +$290K 0.22% 123
2024
Q3 		$8.41M Sell
420,774
-185,459
-31% -$2.88M 0.25% 102
2024
Q2 		$6.78M Sell
606,233
-208,811
-26% -$1.75M 0.2% 177
2024
Q1 		$5.38M Sell
815,044
-67,939
-8% -$371K 0.15% 231
2023
Q4 		$3.99M Buy
+882,983
New +$3.27M 0.12% 238
2021
Q2 		– Sell
-121,657
Closed -$214K – 337
2021
Q1 		$214K Buy
+121,657
New +$278K ﹤0.01% 292

Other funds holding ADMA

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MCM
Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Peregrine Capital Management's ADMA Position: Q2 2026 in Review

Peregrine Capital Management sold out of ADMA Biologics (ADMA) in Q2 2026, closing a stake of 611,826 shares — an estimated $5.51M sold.

Peregrine Capital Management first reported a position in ADMA in Q1 2021 and held it in 11 quarters. The position peaked at $8.6M in Q4 2025. 62 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Peregrine Capital Management reported no remaining ADMA Biologics position as of Q2 2026 after selling out during the quarter.
  • Peregrine Capital Management sold 611,826 ADMA Biologics shares in Q2 2026, an estimated $5.51M.
  • Peregrine Capital Management first reported a position in ADMA Biologics in Q1 2021 and held it in 11 quarters.
  • Peregrine Capital Management's ADMA Biologics position peaked at $8.6M in Q4 2025.
  • 62 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Peregrine Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.